| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2019 | 34.02 | 34.50 | 30.00 | 30.70 | 1,770,363 |
| Sep 16, 2019 | 35.60 | 37.00 | 33.00 | 34.75 | 1,876,210 |
| Sep 13, 2019 | 28.20 | 35.80 | 28.00 | 35.00 | 4,209,656 |
| Sep 12, 2019 | 32.15 | 33.00 | 26.70 | 29.00 | 6,075,169 |
| Sep 11, 2019 | 42.30 | 44.00 | 32.40 | 32.60 | 4,669,405 |
| Name | Futura Medical | Epic | FUM |
|---|---|---|---|
| ISIN | GB0033278473 | Currency | GBX |
| Type | Equity | Trading Segment | ASQ1 |
| Record Status | Active | Trading Status | Regular Trading |
| Industry | Health Care | Sector | Pharmaceuticals |
| EMS | 15,000 | Prev Close | 30.70 |
| Shares in Issue (m) | 204.66 | Market Cap (£m) | 71.63 |
| PE Ratio | -7.85 | Div per Share () | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -4.46 | EPS Growth (%) | -38.08 |
| PEG | 0.21 | DPS Growth (%) | n/a |
| ROCE | -81.81 | Net Gearing | -65.58 |
| Quick Ratio | 5.34 | Current Ratio | 5.35 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 11 Sep | Liberum Capital | Buy | 31.25 | 60.00 | - | Reiterates |
| 10 Sep | Liberum Capital | Buy | 31.25 | 60.00 | - | Reiterates |
| 19 Jun | Liberum Capital | Buy | 31.25 | 60.00 | - | Reiterates |
| 17 Jun | Liberum Capital | Buy | 31.25 | - | 60.00 | Initiates/Starts |
| 23 Mar | N+1 Singer | Corporate | 31.25 | - | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 11 Jan 2019 | Jonathan Freeman | In Lieu of Fees/Salary | 19,578 @ 25.10p | £4,914.08 |
| 11 Jan 2019 | John Clarke | In Lieu of Fees/Salary | 57,250 @ 25.10p | £14,369.75 |
| 13 Nov 2018 | James Barder | Buy | 357,142 @ 7.00p | £24,999.94 |
| 13 Nov 2018 | Jonathan Freeman | Buy | 7,478 @ 7.00p | £523.46 |
| 13 Nov 2018 | Ken James | Buy | 285,714 @ 7.00p | £19,999.98 |
